LIM
DNA icon

Lingotto Investment Management’s Ginkgo Bioworks DNA Stock Holding History

Lingotto Investment Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250,282
Closed -$2.08M – 37
2025
Q4 		$2.08M Hold
250,282
– – 0.04% 38
2025
Q3 		$3.65M Hold
250,282
– – 0.07% 35
2025
Q2 		$2.82M Hold
250,282
– – 0.06% 42
2025
Q1 		$1.43M Hold
250,282
– – 0.04% 44
2024
Q4 		$2.46M Hold
250,282
– – 0.07% 49
2024
Q3 		$2.04M Sell
250,282
-1
-0% -$10 0.06% 44
2024
Q2 		$3.35M Hold
250,283
– – 0.11% 41
2024
Q1 		$11.6M Buy
250,283
+37,500
+18% +$1.94M 0.49% 23
2023
Q4 		$14.4M Buy
212,783
+55,000
+35% +$3.37M 0.69% 22
2023
Q3 		$11.4M Hold
157,783
– – 0.61% 19
2023
Q2 		$11.7M Buy
+157,783
New +$9.34M 0.76% 19

Other funds holding DNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return